Paul Y. Song
CEO & ChairmanDr. Paul Y. Song, M.D. is Consulting & C.M.O of HawkeyeBio, Inc. Dr. Song is Director of PeproMene Bio, Inc. Dr. Song joined Calyx Peak Of Ma, Inc. as Chief Medical Officer in 2017. Dr. Song, a board-certified radiation oncologist in Los Angeles and a partnership was formed. He was a Co-Founder & Chief Executive Officer at Fuse Biotherapeutics, Inc. since July 2021 and served as its Treasurer and Secretary. He has been the Chief Executive Officer since September 2023 and also its Director. Dr. Song served as Secretary, Chief Executive Officer and Vice Chairman of Legacy NKGen from December 2022 to September 2023. He served as Senior Advisor at NKGen Biotech, Inc & serves as it's Chairman since March 14, 2024. Dr. Song served as Vice Chairman and Senior Advisor at NKMAX CO. Ltd until 2023. He had been the Chief Medical Officer at LungLife AI, Inc. (formerly known as Cynvenio Biosystems, Inc.). since September 2015. He was a Senior Medical Advisor at Hawkeye Bio, Inc since July 2017, Partner at Calyx Peak Companies since April 2017, Senior Medical Advisor at Supportive Therapeutics since March 2017, Vice Chairman and Chief Medical Officer at NKMax America, Inc. from October 2019 to January 2021, Visiting Fellow at California Department of Insurance from January 2013 to November 2013, SVP & Chief Medical Officer at BERG Health from June 2009 to November 2011. Dr. Song serves as Chief Medical Officer at AT-Gen Co. Ltd, where he oversees all clinical aspects of its NK-Vue, an ELISA-based blood test which measures natural killer cell activity. He is a Senior Adviser at Berg Health, where he previously served as its Chief Medical Officer. He was responsible for global clinical utility activities including trial definition, institutional partner selection and patient stratification. He coordinates global activities with partners abroad, especially in Europe and China. Dr. Song serves as a Member of Medical Board of Advisors at Prostate Cancer Institute, LLC. He provides editorial advice and review in relation to areas surrounding radiation therapy for prostate cancer. He is a frequent contributor to the Larry King Live show and a Life Changer Expert of Extra TV. A respected clinician and seasoned medical executive with more than two decades experience in the field of oncology, he is also on the faculty at Cedars Sinai Medical Center, in the Samuel Oschin Cancer Center department of radiation oncology and biomedical sciences. He is a board-certified radiation oncologist at the John Wayne Cancer Institute/ Saint John’s Health Center in Santa Monica, CA. Dr. Song BA with honors from the University of Chicago from 1980 to 1987 and received his Medical degree from George Washington University from 1987 to 1991.
Positions
- Company NameNKGen Biotech, Inc.Stock CodeNKGNPositionCEO & ChairmanRelated SecuritiesColleagues
- JAJames A. GrafInterim Chief Financial Officer
- YKYoonmi KangSVP of Technical Ops & Development
- YMYong Man KimChief Scientific Officer
- ICIrene ChangSVP, HR & Corporate Culture
- MLMichael L. KlowdenIndependent Director
- KDKathleen D. ScottIndependent Director
- ATAnthony T. RederMember of Scientific Advisory Board
- CBCraig BlackstoneMember of Scientific Advisory Board
